408 related articles for article (PubMed ID: 28945150)
1. Fibro-Mark: a panel of laboratory parameters for predicting significant fibrosis in chronic hepatitis C patients.
Attallah AM; Omran D; Omran MM; Albannan MS; Zayed RA; Saif S; Farid A; Hassany M; Yosry A
Br J Biomed Sci; 2018 Jan; 75(1):19-23. PubMed ID: 28945150
[TBL] [Abstract][Full Text] [Related]
2. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients.
Omran MM; Farid K; Emran TM; Attallah AA
Arab J Gastroenterol; 2011 Jun; 12(2):74-9. PubMed ID: 21684477
[TBL] [Abstract][Full Text] [Related]
3. Fibro-check: a combination of direct and indirect markers for liver fibrosis staging in chronic hepatitis C patients.
Attallah AM; El-Far M; Abdel Malak CA; Omran MM; Farid K; Hussien MA; Albannan MS; Attallah AA; Elbendary MS; Elbesh DA; Elmenier NA; Abdallah MO
Ann Hepatol; 2015; 14(2):225-33. PubMed ID: 25671832
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].
Kim SM; Sohn JH; Kim TY; Roh YW; Eun CS; Jeon YC; Han DS; Oh YH
Korean J Hepatol; 2009 Dec; 15(4):454-63. PubMed ID: 20037264
[TBL] [Abstract][Full Text] [Related]
5. Fibrogenic/Angiogenic Linker for Non-Invasive Assessment of Hepatic Fibrosis Staging in Chronic Hepatitis C Among Egyptian Patients.
Toson EA; Shiha GE; Abdelgaleel AE
Ann Hepatol; 2017 November-December,; 16(6):862-873. PubMed ID: 29055924
[TBL] [Abstract][Full Text] [Related]
6. The predictive value of noninvasive serum markers of liver fibrosis in patients with chronic hepatitis C.
Gökcan H; Kuzu UB; Öztaş E; Saygılı F; Öztuna D; Suna N; Tenlik İ; Akdoğan M; Kaçar S; Kılıç ZM; Kayaçetin E
Turk J Gastroenterol; 2016 Mar; 27(2):156-64. PubMed ID: 26853790
[TBL] [Abstract][Full Text] [Related]
7. Mean Platelet Volume, Red Cell Distribution Width to Platelet Count Ratio, Globulin Platelet Index, and 16 Other Indirect Noninvasive Fibrosis Scores: How Much Do Routine Blood Tests Tell About Liver Fibrosis in Chronic Hepatitis C?
Thandassery RB; Al Kaabi S; Soofi ME; Mohiuddin SA; John AK; Al Mohannadi M; Al Ejji K; Yakoob R; Derbala MF; Wani H; Sharma M; Al Dweik N; Butt MT; Kamel YM; Sultan K; Pasic F; Singh R
J Clin Gastroenterol; 2016 Jul; 50(6):518-23. PubMed ID: 26974762
[TBL] [Abstract][Full Text] [Related]
8. Five Fibrosis Biomarkers Together with Serum Ferritin Level to Diagnose Liver Fibrosis and Cirrhosis.
Afify SM; Tabll A; Nawara HM; El Kassas M; Elfert A; Seno M; El-Kousy S
Clin Lab; 2018 Oct; 64(10):1685-1693. PubMed ID: 30336529
[TBL] [Abstract][Full Text] [Related]
9. AST/ALT ratio is not useful in predicting the degree of fibrosis in chronic viral hepatitis patients.
Eminler AT; Ayyildiz T; Irak K; Kiyici M; Gurel S; Dolar E; Gulten M; Nak SG
Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1361-6. PubMed ID: 26352130
[TBL] [Abstract][Full Text] [Related]
10. APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B.
Ucar F; Sezer S; Ginis Z; Ozturk G; Albayrak A; Basar O; Ekiz F; Coban S; Yuksel O; Armutcu F; Akbal E
Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1076-81. PubMed ID: 23510962
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis.
Kayadibi H; Yasar B; Ozkara S; Serdar MA; Kurdas OO; Gonen C
Scand J Clin Lab Invest; 2014 Apr; 74(3):240-7. PubMed ID: 24460024
[TBL] [Abstract][Full Text] [Related]
12. FibroQ: an easy and useful noninvasive test for predicting liver fibrosis in patients with chronic viral hepatitis.
Hsieh YY; Tung SY; Lee IL; Lee K; Shen CH; Wei KL; Chang TS; Chuang CS; Wu CS; Lin YH
Chang Gung Med J; 2009; 32(6):614-22. PubMed ID: 20035640
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection.
Schiavon LL; Narciso-Schiavon JL; Carvalho Filho RJ; Sampaio JP; Medina-Pestana JO; Lanzoni VP; Silva AE; Ferraz ML
J Viral Hepat; 2008 Sep; 15(9):666-74. PubMed ID: 18482283
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive diagnosis of liver fibrosis and cirrhosis in chronic hepatitis C patients.
Attallah AM; El-Far M; Omran MM; Farid K; Albannan MS; El-Dosoky I
J Clin Lab Anal; 2013 Mar; 27(2):121-9. PubMed ID: 23460258
[TBL] [Abstract][Full Text] [Related]
15. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection.
Fouad SA; Esmat S; Omran D; Rashid L; Kobaisi MH
World J Gastroenterol; 2012 Jun; 18(23):2988-94. PubMed ID: 22736923
[TBL] [Abstract][Full Text] [Related]
17. The PAPAS index: a novel index for the prediction of hepatitis C-related fibrosis.
Ozel BD; Poyrazoğlu OK; Karaman A; Karaman H; Altinkaya E; Sevinç E; Zararsiz G
Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):895-900. PubMed ID: 25951491
[TBL] [Abstract][Full Text] [Related]
18. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.
Fontana RJ; Goodman ZD; Dienstag JL; Bonkovsky HL; Naishadham D; Sterling RK; Su GL; Ghosh M; Wright EC;
Hepatology; 2008 Mar; 47(3):789-98. PubMed ID: 18175357
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients.
Erdogan S; Dogan HO; Sezer S; Uysal S; Ozhamam E; Kayacetin S; Koca Y
Scand J Clin Lab Invest; 2013; 73(4):300-8. PubMed ID: 23514016
[TBL] [Abstract][Full Text] [Related]
20. A panel of a mitogenic (PDGF), biochemical (albumin) and demographic (age) parameters for the non-invasive assessment of hepatic fibrosis.
Attallah AM; Albannan MS; Omran MM; Zayed R; Saif S; Farid A; Hassany M; Yosry A; Omran D
Br J Biomed Sci; 2019 Jul; 76(3):105-110. PubMed ID: 30924403
[No Abstract] [Full Text] [Related]
[Next] [New Search]
